SCHEMBL4763165

SCHEMBL4763165

O=c1c([N+](=O)[O-])c(/C=C/c2cnn(Cc3ccccc3C(F)(F)F)c2)n(CCc2ccccc2)c(=O)n1CCc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 3/20 0.43
ADORA1 P30542 3/20 0.43
ADORA2A P29274 2/20 0.43
ALDH1A1 P00352 2/20 0.35
MAPK1 P28482 1/20 0.35
MAPT P10636 1/20 0.35
TDP1 Q9NUW8 1/20 0.34
HDAC2 Q92769 1/20 0.33
C5AR1 P21730 1/20 0.33
THRB P10828 1/20 0.33
SCD5 Q86SK9 1/20 0.33
HSPD1 P10809 1/20 0.33
HSPE1 P61604 1/20 0.33
TAS2R8 Q9NYW2 2/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
LMNA P02545 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4763171 1.00 ADORA2B (0.43) ADORA2BADORA1ADORA2AALDH1A1MAPK1
SCHEMBL4764008 0.93 ADORA2B (0.41) ADORA2BADORA1ADORA2AALDH1A1MAPK1
SCHEMBL4764018 0.93 ADORA2B (0.41) ADORA2BADORA1ADORA2AALDH1A1MAPK1
SCHEMBL4765708 0.90 TP53 (0.41) ADORA2BADORA1ADORA2AALDH1A1MAPT
SCHEMBL4765722 0.90 TP53 (0.41) ADORA2BADORA1ADORA2AALDH1A1MAPT
SCHEMBL4766007 0.89 C5AR1 (0.41) ADORA2BADORA1ADORA2AC5AR1
SCHEMBL4770754 0.89 ADORA2B (0.48) ADORA2BADORA1ADORA2AALDH1A1MAPK1
SCHEMBL4770747 0.89 ADORA2B (0.48) ADORA2BADORA1ADORA2AALDH1A1MAPK1
SCHEMBL4763384 0.88 ADORA2B (0.44) ADORA2BADORA1ADORA2AALDH1A1MAPK1
SCHEMBL4769673 0.87 ADORA2B (0.52) ADORA2BADORA1ADORA2AADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678181-B1 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS INC (US) 2008-12-31 EP disclosed